STIOLTO RESPIMAT Shown an Effective Therapy For Adult COPD Patients
During the recent American College of Chest Physicians Annual Meeting (CHEST 2015) in Montreal, Canada, Boehringer Ingelheim Pharmaceuticals, Inc. presented several positive post-hoc analyses from the TONADO® 1&2 and OTEMTO® 1&2 clinical trials. Phase III TONADO 1&2 (NCT01431274/NCT01431287) and OTEMTO® 1&2 studies evaluated the efficacy and safety of tiotropium/olodaterol delivered via the…